ACETAR BIO-TECH INC.Is a collection of plant active pharmaceutical ingredients,food additives,health food raw materials,such as dietary supplements the research and development,production,sales for the integration of national high and new technology enterprise,the company to serve the human health as the mission,on the basis of high quality,high performance hardware facilities,supported by advanced biological technology at home and abroad,with advanced management concept,innovation and scientific based on excellent management team,committed to the production safety,high efficiency of biological medicinal products.Adhering to the business philosophy of"quality first",the company will continue to maintain and consolidate its leading position in the field of biological health in the future and make outstanding contributions to the big health industry.
In 2007,the company was awarded the title of xi'an high-tech enterprise.In 2009,it passed the ISO9001 quality system certification and obtained the qualification of customs declaration approval.It can directly export trade.In 2012 through the ISO22000 food safety management system and HACCP certification,becoming in shaanxi province in 2015 industrial enterprises above designated size,little giant registration enterprise,in 2016 by Chinese medicine extract production enterprises for the record registration,cGMP certification and organic certification,the food and health care products SC license certificate,2017 through the non-gm product certification,obtained the feed additives production license in 2018.
At present,the company's core products are more than 10 varieties such as ginkgo flavones,st.John's root,scutellaria baicalensis and SC licensed products.Now,the company has more than 100 products on the market,exported to Europe,America,southeast Asia and other regions,well received by customers,and is committed to becoming the core manufacturer and supplier of natural active ingredient extraction industry.The company has two patent products with independent research and development of intellectual property rights,and two plant extraction production lines in zhouzhi county and fengxian county in line with GMP standards.The company has an annual production capacity of 5,000 tons of natural plants,with huge development potential in the future.According to the company's 2019-20213 development plan,the company will further improve its production capacity,product quality and supply chain efficiency in the future.
Through acquisition and investment,the company has established two wholly-owned subsidiaries,xi'an hanhua biotechnology co.,ltd.and zhouzhi tianyi gubentang biotechnology co.,LTD.Xi'an hanhua biotechnology co.,ltd.currently assumes the company's trade and sales functions,zhou zhi county tianyi gubentang biotechnology co.,ltd.currently assumes the company's production base functions.In addition,the company has a branch in baojifeng county,is one of the company's main production bases.
The company successfully applied for listing through the national sme share transfer system on January 28,2015,with the stock code of 831942.It is the first new third board listed company in the plant extraction industry of shaanxi province.In June 2015,the company completed the first round of financing and introduced four legal shareholders,namely zhongyu capital,China merchants securities,northeast securities and cic securities,with a total financing of 18 million yuan(6 million shares).In October 2015,the company completed the second round of financing,mainly for internal core employees and designated natural persons and legal persons,and introduced more than 20 small and medium shareholders led by western investment,raising a total of 14.352 million yuan(4.485 million shares).In 2015,planned social financing of 20 million yuan,actually completed bank credit and social financing of 26.5 million yuan,actual financing of 33 million yuan,the asset-liability ratio decreased by 0.56%compared with 2014.In 2016,two financing projects were completed,the first one was 21 million yuan,the second one was 9 million yuan,the second one was Shanghai duncheng investment company and zhongyu hengshan investment company.In 2018,four institutions led by ping an caizhi were introduced,and the total financing was 66.6 million yuan.
ACETAR BIO-TECH INC. Stick to"rushed,cohesion and vitality,trust,achievement,responsibility"spirit of enterprise,an international perspective,rigorous truth-seeking attitude,use of biological chemistry and related areas of advanced science and technology,the development of modified natural resources,production of high quality,controllable,natural products and related products for clients,and for the extraction of plant industry and the rapid development of Chinese medicine,health care products industry struggling with.
As the first listed traditional Chinese medicine extraction enterprise in shaanxi province,xi'an tianyi biotechnology co.,LTD.On the one hand,by means of the area all the way to bring development opportunity,make good use of xi'an location advantage and economic and cultural advantages,efforts to improve enterprise competitiveness,on the other hand timely steadily carry out the strategy of"going out",seize the opportunity of"area",make full use of traditional Chinese medicine resources in western China,enhance the level of technology and expand market share.
At present,ACETAR BIO-TECH INC.,the proportion of export accounted for about 70%of the total amount of sales,but the main,south of the north American market is given priority to,under the impetus of the"area",the company in the next three to five years,on the one hand,further improve product quality and technical standards,with international advanced technology and services,at the same time,pay more attention to the development of Europe,Asia,the Middle East,Africa and other places of the market,so as to get rid of the dependence on the American market,achieve the equilibrium of company marketing strategy and market cultivating fine goal,finally realizes the company internationalization development goals.